Determining the presence of periodontopathic virulence factors in short-term postmortem Alzheimer's disease brain tissue

Journal of Alzheimer's Disease

Volumn 36, Issue 4, 2013, Pages 665-677

  Poole, Sophie ^a   Singhrao, Sim K ^a   Kesavalu, Lakshmyya ^b   Curtis, Michael A ^c   Crean, StJohn ^a  

^a UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^b UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Alzheimer's disease; lipopolysaccharide; periodontal disease; Porphyromonas gingivalis; postmortem

Indexed keywords

LIPOPOLYSACCHARIDE; VIRULENCE FACTOR;

ADULT; AGED; ALZHEIMER DISEASE; ANTIBODY LABELING; ANTIGEN RETRIEVAL; ARTICLE; ASTROCYTE; AUTOPSY; BACTERIAL VIRULENCE; BRAIN TISSUE; COLORIMETRY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ELECTROPHORESIS; HUMAN; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IN VITRO STUDY; MOLECULAR WEIGHT; NONHUMAN; PARIETAL LOBE; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; POSTMORTEM CHANGE; PRIORITY JOURNAL; TANNERELLA FORSYTHENSIS; TREPONEMA DENTICOLA;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; CELL LINE, TRANSFORMED; DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIODONTAL DISEASES; PORPHYROMONAS GINGIVALIS; TIME FACTORS; TREPONEMA DENTICOLA; VIRULENCE FACTORS; YOUNG ADULT;

EID: 84881414476     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-121918     Document Type: Article

References (65)

1. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL (1998) Microbial complexes in subgingival plaque. J Clin Periodontol 25, 134-144.
2. Paster B, Olsen I, Aas J, Dewhirst F (2006) The breadth of bacterial diversity in the human periodontal pocket and other oral sites. Periodontology 2000 42, 80-87.
3. Burt B (2005) Position paper: Epidemiology of periodontal diseases. J Periodontol 76, 1406-1419.
4. Haffajee AD, Socransky SS, Dzink JL, Taubman MA, Ebersole JL, Smith DJ (1988) Clinical, microbiological and immunological features of subjects with destructive periodontal diseases. J Clin Periodontol 15, 240-246.
5. Lockhart PB, Brennan MT, Sasser HC, Fox PC, Paster BJ, Bahrani-Mougeot FK (2008) Bacteremia associated with toothbrushing and dental extraction. Circulation 117, 3118-3125.
6. Bahrani-Mougeot FK, Paster BJ, Coleman S, Ashar J, Barbuto S, LockhartPB(2008) Diverse and novel oral bacterial species in blood following dental procedures. J Clin Microbiol 46, 2129-2132.
7. Wu T, Trevisan M, Genco RJ, Dorn JP, Falkner KL, Sempos CT (2000) Periodontal disease and risk of cerebrovascular disease: The first national health and nutrition examination survey and its follow-up study. Arch Intern Med 160, 2749-2755.
8. Offenbacher S, KatzV, Fertik G, Collins J,Boyd D, Maynor G, McKaig R, Beck J (1996) Periodontal infection as a possible risk factor for preterm low birth weight. J Periodontol 67, 1103-1113.
9. Lopez NJ, Smith PC, Gutierrez J (2002) Higher risk of preterm birth and lowbirth weight inwomen with periodontal disease. J Dent Res 81, 58-63.
10. Grossi SG, Genco RJ (1998) Periodontal disease and diabetes mellitus: A two-way relationship. Ann Periodontol 3, 51-61.
11. TaylorGW, BorgnakkeWS (2008) Periodontal disease: Associations with diabetes, glycemic control and complications. Oral Dis 14, 191-203.
12. Scannapieco FA, Mylotte JM (1996) Relationships between periodontal disease and bacterial pneumonia. J Periodontol 67, 1114-1122.
13. Craig RG (2008) Interactions between chronic renal disease and periodontal disease. Oral Dis 14, 1-7.
14. Gleissner C,Willershausen B, Kaesser U, BoltenWW(1998) The role of risk factors for periodontal disease in patients with rheumatoid arthritis. Eur J Med Res 3, 387-392.
15. Pischon N, Pischon T, Kroger J, Gulmez E, Kleber BM, Bernimoulin JP, Landau H, Brinkmann PG, Schlattmann P, Zernicke J, Buttgereit F, Detert J (2008) Association among rheumatoid arthritis, oral hygiene, and periodontitis. J Periodontol 79, 979-986.
16. Stein PS, Desrosiers M, Donegan SJ, Yepes JF, Kryscio RJ (2007) Tooth loss, dementia and neuropathology in the Nun study. J Am Dent Assoc 138, 1314-1322.
17. Itzhaki RF, Wozniak MA (2006) Herpes simplex virus type 1, apolipoprotein E, and cholesterol: A dangerous liaison in Alzheimer's disease and other disorders. Prog Lipid Res 45, 73-90.
18. Balin BJ, Little CS, Hammond CJ, Appelt DM, Whittum-Hudson JA, Ǵerard HC, Hudson AP (2008) Chlamydophila pneumoniae and the etiology of late-onset Alzheimer's disease. J Alzheimers Dis 13, 371-380.
19. Miklossy J (2011) Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria. J Neuroinflammation 8, 90-106.
20. Miklossy J (2011) Emerging roles of pathogens in Alzheimer's disease. Expert Rev Mol Med 13, e30.
21. Alzheimer A (1907) Ueber eine eigennartige Erkrankung der Hirnrinde. Allgemeine zeitschrift fur psychiatrie 64, 146-148.
22. Tomlinson BE, Corsellis JAN (1984) Aging and the dementias. In Greenfields Neuropathology, 4th ed. Adams HJ, Corsellis JAN, Duchen LW, eds. Edward Arnold, p. 951.
23. Perry VH, Nicoll JA, Holmes C (2010) Microglia in neurodegenerative disease. Nat Rev Neurol 6, 193-201.
24. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, StreitW, Strohmeyer R, Tooyoma I, VanMuiswinkel FL,Veerhuis R,Walker D,Webster S,Wegrzyniak B,Wenk G, Wyss-Coray T (2000) Inflammation and Alzheimer's disease. Neurobiol Aging 21, 383-421.
25. Sheng JG, Bora SH, Xu G, Borchelt DR, Price DL, Koliatsos VE (2003) Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice. Neurobiol Dis 14, 133-145.
26. Little CS, Hammond CJ, MacIntyre A, Balin BJ, Appelt DM (2004) Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice. Neurobiol Aging 25, 419-429.
27. Cunningham C, Wilcockson DC, Campion S, Lunnon K, Perry VH (2005) Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J Neurosci 25, 9275-9284.
28. Tanaka S, Ide M, Shibutani T, Ohtaki H, Numazawa S, Shioda S, Yoshida T (2006) Lipopolysaccharide-induced microglial activation induces learning and memory deficits without neuronal cell death in rats. J Neurosci Res 83, 557-566.
29. Markiewski MM, Lambris JD (2007) The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am J Pathol 171, 715-727.
30. TaubmanMA,KawaiT(2001) Involvement ofT-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Crit Rev Oral Biol Med 12, 125-135.
31. Arenzana-Seisdedos F, Virelizier JL, FiersW(1985) Interferons as macrophage-activating factors. III. Preferential effects of interferon-gamma on the interleukin 1 secretory potential of fresh or aged human monocytes. J Immunol 134, 2444-2448.
32. Sundqvist G, Carlsson J, Herrmann B, Tärnvik A (1985) Degradation of human immunoglobulins G and M and complement factors C3 and C5 by black-pigmented Bacteroides. J Med Microbiol 19, 85-94.
33. Okuda K, Kato T, Naito Y, Ono M, Kikuchi Y, Takazoe I (1986) Susceptibility of Bacteroides gingivalis to bactericidal activity of human serum. J Dent Res 65, 1024-1027.
34. Schenkein HA (1989) Failure of Bacteroided gingivalis W83 to accumulate bound C3 following opsonisation with serum. J Periodont Res 24, 20-27.
35. Slaney JM, Gallagher A, Aduse-Opoku J, Pell K, Curtis MA(2006) Mechanisms of resistance of Porphyromonas gingivalis to killing by serum complement. Infect Immun 74, 5352-5361.
36. Oldfield BJ, Mckinley MJ (1995) Circumventricular organs. In The Rat Nervous System, Paxinos G, ed. Academic Press, San Diego, pp. 391-403.
37. Lacroix S, Feinstein D, Rivest S (1998) The bacterial endotoxin lipopolysaccharide has the ability to target the brain in upregulating its membrane CD14 receptor within specific cellular populations. Brain Pathol 8, 625-640.
38. Rivest S (2009) Regulation of innate immune responses in the brain. Nat Rev Immunol 9, 429-439.
39. Laflamme N, Rivest S (2001) Toll-like receptor 4: The missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components. FASEB J 15, 155-163.
40. Beutler B, Hoebe K, Du X, Ulevitch RJ (2003) Howwe detect microbes and respond to them: The Toll-like receptors and their transducers. J Leukocyte Biol 74, 479-485.
41. Stein PS, Kryscio RJ, Desrosiers M, Donegan SJ, Gibbs MB (2010) Tooth loss, apolipoprotein E, and decline in delayed word recall. J Dent Res 89, 473-477.
42. Buttini M, Masliah E, Yu GQ, Palop JJ, Chang S, Bernardo A, Lin C, Wyss-Coray T, Huang Y, Mucke L (2010) Cellular source of apolipoprotein E4 determines neuronal susceptibility to excitotoxic injury in transgenic mice. Am J Pathol 177, 563-569.
43. Kamer AR, Craig RG, Pirraglia E, Dasanayake AP, Norman RG, Boylan RJ, Nehorayoff A, Glodzik L, Brys M, de Leon MJ (2009) TNF-alpha and antibodies to periodontal bacteria discriminate between Alzheimer's disease patients and normal subjects. J Neuroimmunol 216, 92-97.
44. Sparks Stein PS, Steffen MJ, Smith C, Jicha G, Ebersole JL, Abner E, Dawson D (2012) Serum antibodies to periodontal pathogens are a risk factor for Alzheimer's disease. Alzheimers Dement 8, 196-203.
45. Riviere GR, Riviere KH, Smith KS (2002) Molecular and immunological evidence of oral Treponema in the human brain and their association with Alzheimer's disease. Oral Microbiol Immunol 17, 113-118.
46. Foschi F, Izard J, Sasaki H, Sambri V, Prati C, Müller R, Stashenko P (2006) Treponema denticola in disseminating endodontic infections. J Dent Res 85, 761-765.
47. Curtis MA, Thickett A, Slaney JM, Rangarajan M, Aduse-Opoku J, Shepherd P, Paramonov N, Hounsell EF (1999) Variable carbohydrate modifications to the catalytic chains of the RgpA and RgpB proteases of Porphyromonas gingivalis W50. Infect Immun 67, 3816-3823.
48. Curtis MA, Aduse-Opoku J, Slaney JM, Rangarajan M, Booth V, Cridland J, Shepherd P (1996) Characterization of an adherence and antigenic determinant of the ArgI protease of Porphyromonas gingivalis which is present on multiple gene products. Infect Immun 64, 2532-2539.
49. Marcotte H, K̃oll-Klais P, Hultberg A, Zhao Y, Gmür R, Mändar R, Mikelsaar M, Hammarström L (2006) Expression of single-chain antibody against RgpA protease of Porphy romonas gingivalis in Lactobacillus. J Appl Microbiol 100, 256-263.
50. Sharma A, Sojar HT, Glurich I, Honma K, Kuramitsu HK, Genco RJ (1998) Cloning, expression and sequencing of a cell surface antigen containing a leucine-rich repeat motif from bacteroides forsythus ATCC 43037. Infect Immun 66, 5703-5710.
51. ParamonovN, Rangarajan M, Hashim A, Gallagher A, Aduse-Opoku J, Slaney JM, Hounsell E, CurtisMA(2005) Structural analysis of a novel anionic polysaccharide from Porphyromonas gingivalis strain W50 related to Arg-gingipain glycans. Mol Microbiol 58, 847-863.
52. Miller WD (1891) The human mouth as a focus of infection. Dent Cosmos 33, 689-713.
53. Hunter WD (1900) Oral sepsis as a cause of disease. Br Med J 2, 215-216.
54. Hammond C, Hallock L, Howanski R, Appelt D, Little S, Balin, B (2010) Immunohistological detection of Chlamydia pheumoniae in the Alzheimer's disease brain BMC Neurosci 11, 121-132.
55. Slots J, Genco RJ (1984) Black-pigmented Bacteroides species, Capnocytophaga species, and Actinobacillus actinomycetemcomitans in human periodontal disease: Virulence factors in colonization, survival, and tissue destruction. J Dent Res 63, 412-421.
56. Slots J, Listgarten MA (1988) Bacteroides gingivalis, Bacteroides intermedius and Actinobacillus actinomycetemcomitans in human periodontal diseases. J Clin Periodontol 15, 85-93.
57. Arai K, Sumi Y, Uematsu H, Miura H (2003) Association between dental health behaviours, mental/physical function and self-feeding ability among the elderly: A cross-sectional survey. Gerodontology 20(2), 78-83.
58. Henry RG, Wekstein DR (1997) Providing dental care for patients diagnosed with Alzheimer's disease. Dent Clin North Am 41, 915-943.
59. Shimazaki Y, Soh I, Saito T, Yamashita Y, Koga T, Miyazaki H, Takehara T (2001) Influence of dentition status on physical disability, mental impairment and mortality in institutionalized elderly people. J Dent Res 80, 340-345.
60. Philip P, Rogers C, Kruger E, TennantM(2012) Oral hygiene care status of elderly with dementia and in residential aged care facilities. Gerodontology 29, e306-11.
61. Holmes C, El-Okl M,Williams AL, Cunningham C,Wilcockson D, Perry, V (2003) Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry 74, 788-789.
62. Holmes C, Cunningham C, Zotova E, Woolford J, Dean C, Kerr S, Culliford D, Perry VH (2009) Systemic inflammation and disease progression in Alzheimer's disease. Neurology 73, 768-774.
63. Grenier D, Mayrand D (1987) Functional characterization of extracellular vesicles produced by Bacteroides gingivalis. Infect Immun 55, 111-117.
64. Holt SC,Kesavalu L,Walker SG, GencoCA(1999)Virulence factors of Porphyromonas gingivalis. Periodontology 2000 168-239.
65. Scragg MA, Alsam A, Rangarajan M, Slaney JM, Shepherd P,Williams DM, CurtisMA(2002). Nuclear targeting of Porphyromonas gingivalis W50 protease in epithelial cells. Infect Immun 70, 5740-5750.